Key facts
| Price (PPV) | 15,010 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | vémurafénib |
| Class | Antineoplastic agents |
| ATC code | L01EC01 |
| Manufacturer | ROCHE S.A |
| Presentation | Boite de 56 |
| Nature | Médicament |
| Hospital price | 14,724 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de patients souffrant de mélanome non résécable ou métastatique à gène BRAF porteur de la mutation V600. Source : Compendium.ch - Date : 20 octobre 2025
Find an open pharmacy
On-call pharmacies near you
About Zelboraf 240 mg
Zelboraf 240 mg belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by ROCHE S.A and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Zelboraf 240 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Zelboraf 240 mg
Answers to common questions from Moroccan patients about this drug.